Svilenov HL - Search Results

1

Specific features of a scaffolding antibody light chain.

Trommer J, Lesniowski F, Buchner J, Svilenov HL. Trommer J, et al. Among authors: svilenov hl. Protein Sci. 2024 May;33(5):e4990. doi: 10.1002/pro.4990. Protein Sci. 2024. PMID: 38607241 Free PMC article.

2

Chemometrics in Protein Formulation: Stability Governed by Repulsion and Protein Unfolding.

Kulakova A, Augustijn D, El Bialy I, Gentiluomo L, Greco ML, Hervø-Hansen S, Indrakumar S, Mahapatra S, Martinez Morales M, Pohl C, Polimeni M, Roche A, Svilenov HL, Tosstorff A, Zalar M, Curtis R, Derrick JP, Frieß W, Golovanov AP, Lund M, Nørgaard A, Khan TA, Peters GHJ, Pluen A, Roessner D, Streicher WW, van der Walle CF, Warwicker J, Uddin S, Winter G, Bukrinski JT, Rinnan Å, Harris P. Kulakova A, et al. Among authors: svilenov hl. Mol Pharm. 2023 Jun 5;20(6):2951-2965. doi: 10.1021/acs.molpharmaceut.3c00013. Epub 2023 May 5. Mol Pharm. 2023. PMID: 37146162

3

Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2.

Svilenov HL, Delhommel F, Siebenmorgen T, Rührnößl F, Popowicz GM, Reiter A, Sattler M, Brockmeyer C, Buchner J. Svilenov HL, et al. Commun Biol. 2023 Apr 8;6(1):386. doi: 10.1038/s42003-023-04762-w. Commun Biol. 2023. PMID: 37031320 Free PMC article.

4

Principles of antibodies with ultralong complementarity-determining regions and picobodies.

Passon M, De Smedt S, Svilenov HL. Passon M, et al. Among authors: svilenov hl. Biotechnol Adv. 2023 May-Jun;64:108120. doi: 10.1016/j.biotechadv.2023.108120. Epub 2023 Feb 9. Biotechnol Adv. 2023. PMID: 36764335 Review.

5

Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties.

Svilenov HL, Arosio P, Menzen T, Tessier P, Sormanni P. Svilenov HL, et al. MAbs. 2023 Jan-Dec;15(1):2164459. doi: 10.1080/19420862.2022.2164459. MAbs. 2023. PMID: 36629855 Free PMC article.

6

Get what you want: Identifying antibodies against pre-defined epitopes on Frizzled receptors.

Svilenov HL. Svilenov HL. Structure. 2023 Jan 5;31(1):2-3. doi: 10.1016/j.str.2022.12.004. Structure. 2023. PMID: 36608664 Free article.

7

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants.

Svilenov HL, Bester R, Sacherl J, Absmeier R, Peters C, Protzer U, Brockmeyer C, Buchner J. Svilenov HL, et al. Commun Biol. 2022 Nov 12;5(1):1237. doi: 10.1038/s42003-022-04193-z. Commun Biol. 2022. PMID: 36371561 Free PMC article.

8

Insights into the Stabilization of Interferon Alpha by Two Surfactants Revealed by STD-NMR Spectroscopy.

Svilenov HL, Kopp KT, Golovanov AP, Winter G, Zalar M. Svilenov HL, et al. J Pharm Sci. 2023 Feb;112(2):404-410. doi: 10.1016/j.xphs.2022.10.013. Epub 2022 Oct 17. J Pharm Sci. 2023. PMID: 36257338 Free article.

9

It is Never Too Late for a Cocktail - Development and Analytical Characterization of Fixed-dose Antibody Combinations.

Krieg D, Winter G, Svilenov HL. Krieg D, et al. Among authors: svilenov hl. J Pharm Sci. 2022 Aug;111(8):2149-2157. doi: 10.1016/j.xphs.2022.05.014. Epub 2022 May 19. J Pharm Sci. 2022. PMID: 35598781 Review.

10

Antibodies gone bad - the molecular mechanism of light chain amyloidosis.

Absmeier RM, Rottenaicher GJ, Svilenov HL, Kazman P, Buchner J. Absmeier RM, et al. Among authors: svilenov hl. FEBS J. 2023 Mar;290(6):1398-1419. doi: 10.1111/febs.16390. Epub 2022 Feb 17. FEBS J. 2023. PMID: 35122394 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page